NCAN and metabolic dysfunction-associated steatotic liver disease: We found no carriers with TT genotype both in NAFLD and control group, also no significant association of NCAN rs2228603 with NAFLD was observed in our subjects, which latter was consistent with some previous findings [32, 34, 35].